GB9810920D0 - Therapeutic use - Google Patents

Therapeutic use

Info

Publication number: GB9810920D0
Authority: GB; United Kingdom
Prior art keywords: therapeutic use; therapeutic
Prior art date: 1998-05-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB9810920.0A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Organon Pharma UK Ltd

Original Assignee

Merck Sharp and Dohme Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-21

Filing date

1998-05-21

Publication date

1998-07-22

1998-05-21 Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd

1998-05-21 Priority to GBGB9810920.0A priority Critical patent/GB9810920D0/en

1998-07-22 Publication of GB9810920D0 publication Critical patent/GB9810920D0/en

1999-05-19 Priority to CA002327585A priority patent/CA2327585A1/en

1999-05-19 Priority to JP2000549299A priority patent/JP2002515461A/en

1999-05-19 Priority to AU39486/99A priority patent/AU758983B2/en

1999-05-19 Priority to EP99922393A priority patent/EP1079863A1/en

1999-05-19 Priority to PCT/GB1999/001632 priority patent/WO1999059635A1/en

2003-07-07 Priority to US10/614,389 priority patent/US20040097573A1/en

Status Ceased legal-status Critical Current

Links

230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

GBGB9810920.0A 1998-05-21 1998-05-21 Therapeutic use Ceased GB9810920D0 (en)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
GBGB9810920.0A GB9810920D0 (en)	1998-05-21	1998-05-21	Therapeutic use
CA002327585A CA2327585A1 (en)	1998-05-21	1999-05-19	Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation
JP2000549299A JP2002515461A (en)	1998-05-21	1999-05-19	Use of COX-2 inhibitors and NK-1 receptor antagonists for the treatment of inflammation
AU39486/99A AU758983B2 (en)	1998-05-21	1999-05-19	Use of a COX-2 inhibitor and a NK-1 receptor antagonist for treating inflammation
EP99922393A EP1079863A1 (en)	1998-05-21	1999-05-19	Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation
PCT/GB1999/001632 WO1999059635A1 (en)	1998-05-21	1999-05-19	Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation
US10/614,389 US20040097573A1 (en)	1998-05-21	2003-07-07	Use of a COX-2 inhibitor and a NK-1 receptor antagonist for treating inflammation

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9810920.0A GB9810920D0 (en)	1998-05-21	1998-05-21	Therapeutic use

Publications (1)

Publication Number	Publication Date
GB9810920D0 true GB9810920D0 (en)	1998-07-22

Family

ID=10832454

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9810920.0A Ceased GB9810920D0 (en)	1998-05-21	1998-05-21	Therapeutic use

Country Status (6)

Country	Link
EP (1)	EP1079863A1 (en)
JP (1)	JP2002515461A (en)
AU (1)	AU758983B2 (en)
CA (1)	CA2327585A1 (en)
GB (1)	GB9810920D0 (en)
WO (1)	WO1999059635A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003082191A2 (en)	2002-03-28	2003-10-09	Merck & Co., Inc.	Substituted 2,3-diphenyl pyridines
KR20040072004A (en)	2003-02-07	2004-08-16	삼성에스디아이 주식회사	Emitting compound for electroluminescence device and device using thereof
DK1534305T3 (en)	2003-05-07	2007-02-05	Osteologix As	Treatment of cartilage / bone disorders with water-soluble strontium salts
WO2006081088A2 (en) *	2005-01-24	2006-08-03	Pozen Inc.	Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an nsaid

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2099233A1 (en) *	1992-06-29	1993-12-30	Conrad P. Dorn	Morpholine and thiomorpholine tachykinin receptor antagonists
GB2287404A (en) *	1994-03-15	1995-09-20	Pfizer	Antiinflammatory and analgesic compositions
KR100517210B1 (en) *	1994-12-12	2006-06-07	오메로스 코포레이션	Infusion solution for pain, inflammation and spasm
GB9426103D0 (en) *	1994-12-23	1995-02-22	Merck Sharp & Dohme	Therapeutic agents
JPH11501049A (en) *	1995-04-04	1999-01-26	グラクソ、グループ、リミテッド	Imidazo [1,2-a] pyridine derivative
WO1997025988A1 (en) *	1996-01-17	1997-07-24	Eli Lilly And Company	Methods of treating or preventing pain or nociception
ES2188971T3 (en) *	1996-08-14	2003-07-01	Searle & Co	CRYSTAL FORM OF THE 4- (5-METHYL-3-PHENYLISOXAZOL-4-IL) BENZENSULFONAMIDE.
US5750549A (en) *	1996-10-15	1998-05-12	Merck & Co., Inc.	Cycloalkyl tachykinin receptor antagonists

1998
- 1998-05-21 GB GBGB9810920.0A patent/GB9810920D0/en not_active Ceased
1999
- 1999-05-19 CA CA002327585A patent/CA2327585A1/en not_active Abandoned
- 1999-05-19 AU AU39486/99A patent/AU758983B2/en not_active Ceased
- 1999-05-19 EP EP99922393A patent/EP1079863A1/en not_active Withdrawn
- 1999-05-19 WO PCT/GB1999/001632 patent/WO1999059635A1/en not_active Application Discontinuation
- 1999-05-19 JP JP2000549299A patent/JP2002515461A/en not_active Withdrawn

Also Published As

Publication number	Publication date
WO1999059635A1 (en)	1999-11-25
CA2327585A1 (en)	1999-11-25
EP1079863A1 (en)	2001-03-07
AU3948699A (en)	1999-12-06
JP2002515461A (en)	2002-05-28
AU758983B2 (en)	2003-04-03

Legal Events

Date	Code	Title	Description
1999-08-18	AT	Applications terminated before publication under section 16(1)

Publication	Publication Date	Title
GB9820113D0 (en)	1998-11-11	Therapeutic agents
GB9816263D0 (en)	1998-09-23	Therapeutic agents
GB9806102D0 (en)	1998-05-20	Therapeutic agents
GB9804885D0 (en)	1998-04-29	Therapeutic combination
GB9808663D0 (en)	1998-06-24	Therapeutic agents
GB9801234D0 (en)	1998-03-18	Therapeutic agents
GB9813576D0 (en)	1998-08-19	Therapeutic agents
GB9813006D0 (en)	1998-08-12	Therapeutic agents
GB9801210D0 (en)	1998-03-18	Therapeutic agents
AP9901436A0 (en)	1999-03-31	Therapeutic agents
GB9801397D0 (en)	1998-03-18	Therapeutic agents
GB9801202D0 (en)	1998-03-18	Therapeutic agents
GB9810092D0 (en)	1998-07-08	Therapeutic agents
GB9811879D0 (en)	1998-07-29	Therapeutic agents
GB9819484D0 (en)	1998-10-28	Therapeutic agents
GB9810920D0 (en)	1998-07-22	Therapeutic use
GB9816897D0 (en)	1998-09-30	Therapeutic use
GB9812662D0 (en)	1998-08-12	Therapeutic use
GB9815317D0 (en)	1998-09-16	Therapeutic agents
GB9805716D0 (en)	1998-05-13	Therapeutic agents
GB9817838D0 (en)	1998-10-14	Therapeutic agents
GB9821179D0 (en)	1998-11-25	Therapeutic use
GB9811624D0 (en)	1998-07-29	Therapeutic use
GB9816723D0 (en)	1998-09-30	Therapeutic agents
GB9812664D0 (en)	1998-08-12	Therapeutic use